4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow Malignant Neoplasm of Breast: new trials by email Literature Review of Malignant Neoplasm of Breast trials Research Report on Malignant Neoplasm of Breast
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MIRs 04 : Interpectoral Nerve Block With Ropivacaine Versus Placebo Before Breast Cancer Surgery Saline, Ropivacaine - Malignant Neoplasm of Breast | Phase 3 | Completed | Institut Curie | 182 | 2020-08-04 | 2025-09-19 |
| Comparing Efficacy and Safety of AryoGen Pharmed Biosimilar Trastuzumab (AryoTrust) Versus Herceptin® in Breast Cancer Trastuzumab plus docetaxel (for four 21-day cycles) after four 14-day cycles of Doxorubicin plus cyclophosphamide - Malignant Neoplasm of Breast | Phase 3 | Completed | AryoGen Pharmed Co. | 108 | 2016-07-09 | 2024-06-28 |
| MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer Surgery Saline, Ropivacaine - Malignant Neoplasm of Breast | Phase 3 | Completed | Institut Curie | 380 | 2015-03-27 | 2019-07-10 |
| Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer vinflunine, Capecitabine - Malignant Neoplasm of Breast | Phase 3 | Completed | Pierre Fabre Medicament | 112 | 2013-09-01 | 2019-05-02 |
Breast Neoplasms (4) · Chronic Pain (1)
Breast Diseases (4) · Neoplasms (4) · Neoplasms by Site (4) · Skin Diseases (4) · Skin and Connective Tissue Diseases (4) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Ropivacaine (2) · Sodium Chloride (2) · Capecitabine (1) · Cyclophosphamide (1) · Docetaxel (1) · Trastuzumab (1) · vinflunine (1)
Institut Curie (2) · AryoGen Pharmed Co. (1) · Pierre Fabre Medicament (1)
France (2) · China (1) · Iran (1) · Singapore (1) · Taiwan (1)
Binghe XU, MD (1) · Reza Safaei, M.D (1)
PMID 11020770, PMID 16698416, PMID 19903919, PMID 23340346, PMID 23340351, PMID 40068583